William Shipley

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Talcott James A; Rossi Carl; Shipley William U; Clark Jack A; Slater Jerry D; Niemierko Andrzej; Zietman Anthony L
Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.
Viswanathan Akila N; Yorke Ellen D; Marks Lawrence B; Eifel Patricia J; Shipley William U
Radiation dose-volume effects of the urinary bladder.
Zietman Anthony L; Bae Kyounghwa; Slater Jerry D; Shipley William U; Efstathiou Jason A; Coen John J; Bush David A; Lunt Margie; Spiegel Daphna Y; Skowronski Rafi; Jabola B Rodney; Rossi Carl J
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of William Shipley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Talcott James A; Rossi Carl; Shipley William U; Clark Jack A; Slater Jerry D; Niemierko Andrzej; Zietman Anthony L
Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.
JAMA : the journal of the American Medical Association 2010;303(11):1046-53.
2010: Viswanathan Akila N; Yorke Ellen D; Marks Lawrence B; Eifel Patricia J; Shipley William U
Radiation dose-volume effects of the urinary bladder.
International journal of radiation oncology, biology, physics 2010;76(3 Suppl):S116-22.
2010: Zietman Anthony L; Bae Kyounghwa; Slater Jerry D; Shipley William U; Efstathiou Jason A; Coen John J; Bush David A; Lunt Margie; Spiegel Daphna Y; Skowronski Rafi; Jabola B Rodney; Rossi Carl J
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(7):1106-11.
2010: Efstathiou Jason A; Shipley William U; Zietman Anthony L; Smith Matthew R
Hormonal therapies: ADT for prostate cancer: true love or heartbreak?
Nature reviews. Clinical oncology 2010;7(3):130-2.
2009: Pollack Alan; Bae Kyounghwa; Khor Li-Yan; Al-Saleem Tahseen; Hammond M Elizabeth; Venkatesan Varagur; Byhardt Roger W; Asbell Sucha O; Shipley William U; Sandler Howard M
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5478-84.
2009: Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Kaufman Donald S; Hagan Michael P; Heney Niall M; Sandler Howard M
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4055-61.
2009: Ross Robert W; Zietman Anthony L; Xie Wanling; Coen John J; Dahl Douglas M; Shipley William U; Kaufman Donald S; Islam Tina; Guimaraes Alexander R; Weissleder Ralph; Harisinghani Mukesh
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
Clinical imaging 2009;33(4):301-5.
2009: Kaufman Donald S; Shipley William U; Feldman Adam S
Bladder cancer.
Lancet 2009;374(9685):239-49.
2009: Wo Jennifer Y; Shipley William U; Dahl Douglas M; Coen John J; Heney Niall M; Kaufman Donald S; Zietman Anthony L
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
BJU international 2009;104(2):179-83.
2009: Heney Niall M; Kaufman Donald S; Shipley William U
Surgery: selective bladder-preserving therapy for muscle-invasive cancer.
Nature reviews. Clinical oncology 2009;6(4):193-4.
2009: Kaufman Donald S; Winter Kathryn A; Shipley William U; Heney Niall M; Wallace H James; Toonkel Leonard M; Zietman Anthony L; Tanguay Simon; Sandler Howard M
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Urology 2009;73(4):833-7.
2009: Zhang Min; Ho Alex; Hammond Elizabeth H; Suzuki Yoshiyuki; Bermudez R Scott; Lee R Jeffrey; Pilepich Michael; Shipley William U; Sandler Howard; Khor Li-Yan; Pollack Alan; Chakravarti Arnab
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
International journal of radiation oncology, biology, physics 2009;73(4):1033-42.
2009: Ray Michael E; Bae Kyounghwa; Hussain Maha H A; Hanks Gerald E; Shipley William U; Sandler Howard M
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.
Journal of the National Cancer Institute 2009;101(4):228-36.
2009: Montie James E; Clark Peter E; Eisenberger Mario A; El-Galley Rizk; Greenberg Richard E; Herr Harry W; Hudes Gary R; Kuban Deborah A; Kuzel Timothy M; Lange Paul H; Lele Subodh M; Michalski Jeffrey; Patterson Anthony; Pohar Kamal S; Richie Jerome P; Sexton Wade J; Shipley William U; Small Eric J; Trump Donald L; Walther Phillip J; Wilson Timothy G;
Bladder cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(1):8-39.
2009: Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):92-9.
2008: Mak Raymond H; Zietman Anthony L; Heney Niall M; Kaufman Donald S; Shipley William U
Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
BJU international 2008;102(9 Pt B):1345-53.
2008: Taussky Daniel; Bae Kyounghwa; Bahary Jean-Paul; Roach Mack; Lawton Colleen A; Shipley William U; Sandler Howard M
Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.
Urology 2008;72(5):1125-9.
2008: Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.
European urology 2008;54(4):816-23.
2008: Smith Matthew R; Bae Kyounghwa; Efstathiou Jason A; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Shipley William U
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4333-9.
2008: Curran Walter J; Machtay Mitchell; Wasserman Todd; Shipley William U
Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary.
International journal of radiation oncology, biology, physics 2008;71(2):321-3.
2008: Horwitz Eric M; Bae Kyounghwa; Hanks Gerald E; Porter Arthur; Grignon David J; Brereton Harmar D; Venkatesan Varagur; Lawton Colleen A; Rosenthal Seth A; Sandler Howard M; Shipley William U
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2497-504.
2008: Lawton Colleen A; Bae Kyoungwha; Pilepich Miljenko; Hanks Gerald; Shipley William
Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
International journal of radiation oncology, biology, physics 2008;70(2):437-41.
2008: John Subhash S; Zietman Anthony L; Shipley William U; Harisinghani Mukesh G
Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
International journal of radiation oncology, biology, physics 2008;71(1 Suppl):S43-7.
2007: Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.
Cancer 2007;110(12):2691-9.
2007: Khor Li-Yan; Bae Kyounghwa; Pollack Alan; Hammond M Elizabeth H; Grignon David J; Venkatesan Varagur M; Rosenthal Seth A; Ritter Mark A; Sandler Howard M; Hanks Gerald E; Shipley William U; Dicker Adam P
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
The lancet oncology 2007;8(10):912-20.
2007: Trofimov Alexei; Nguyen Paul L; Coen John J; Doppke Karen P; Schneider Robert J; Adams Judith A; Bortfeld Thomas R; Zietman Anthony L; Delaney Thomas F; Shipley William U
Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
International journal of radiation oncology, biology, physics 2007;69(2):444-53.
2007: Roach Mack; De Silvio Michelle; Rebbick Timothy; Grignon David; Rotman Marvin; Wolkov Harvey; Fisher Barbara; Hanks Gerald; Shipley William U; Pollack Alan; Sandler Howard; Watkins-Bruner Deborah
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
International journal of radiation oncology, biology, physics 2007;69(1):79-87.
2007: Chakravarti Arnab; DeSilvio Michelle; Zhang Min; Grignon David; Rosenthal Seth; Asbell Sucha O; Hanks Gerald; Sandler Howard M; Khor Li-Yan; Pollack Alan; Shipley William;
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3082-9.
2007: Khor Li Yan; Moughan Jennifer; Al-Saleem Tahseen; Hammond Elizabeth H; Venkatesan Varagur; Rosenthal Seth A; Ritter Mark A; Sandler Howard M; Hanks Gerald E; Shipley William U; Pollack Alan
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3585-90.
2007: Shipley William U
Radiation-sensitizing chemotherapy after transurethral resection as an alternative treatment for high-risk T1 bladder cancer.
Nature clinical practice. Urology 2007;4(1):24-5.
2007: Coen John J; Zietman Anthony L; Kaufman Donald S; Shipley William U
Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer.
Urologic oncology 2007;25(1):76-84.
2006: Tsai Henry K; Katz Matthew S; Coen John J; Zietman Anthony L; Kaufman Donald S; Shipley William U
Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
Urology 2006;68(6):1188-92.
2006: Montie James E; Abrahams Neil A; Bahnson Robert R; Eisenberger Mario A; El-Galley Rizk; Herr Harry W; Hudes Gary R; Kuzel Timothy M; Lange Paul H; Patterson Anthony; Pollack Alan; Richie Jerome P; Sexton Wade J; Shipley William U; Small Eric J; Trump Donald L; Walther Phillip J; Wilson Timothy G;
Bladder cancer. Clinical guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(10):984-1014.
2006: Efstathiou Jason A; Zietman Anthony L; Kaufman Donald S; Heney Niall M; Coen John J; Shipley William U
Bladder-sparing approaches to invasive disease.
World journal of urology 2006;24(5):517-29.
2006: Roach Mack; DeSilvio Michelle; Valicenti Richard; Grignon David; Asbell Sucha O; Lawton Colleen; Thomas Charles R; Shipley William U
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
International journal of radiation oncology, biology, physics 2006;66(3):647-53.
2006: Valicenti Richard K; DeSilvio Michelle; Hanks Gerald E; Porter Arthur; Brereton Harmar; Rosenthal Seth A; Shipley William U; Sandler Howard M;
Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02.
International journal of radiation oncology, biology, physics 2006;66(4):1064-71.
2006: Horwitz Eric M; Levy Lawrence B; Thames Howard D; Kupelian Patrick A; Martinez Alvaro A; Michalski Jeffrey M; Pisansky Thomas M; Sandler Howard M; Shipley William U; Zelefsky Michael J; Zietman Anthony L; Kuban Deborah A
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.
Cancer 2006;107(7):1496-502.
2006: Roach Mack; Hanks Gerald; Thames Howard; Schellhammer Paul; Shipley William U; Sokol Gerald H; Sandler Howard
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
International journal of radiation oncology, biology, physics 2006;65(4):965-74.
2006: Thames Howard D; Kuban Deborah A; DeSilvio Michelle L; Levy Larry B; Horwitz Eric M; Kupelian Patrick A; Martinez Alvaro A; Michalski Jeff M; Pisansky Thomas M; Sandler Howard M; Shipley William U; Zelefsky Michael J; Zietman Anthony L
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.
International journal of radiation oncology, biology, physics 2006;65(4):975-81.
2006: Shipley William U; Desilvio Michelle; Pilepich Michael V; Roach Mack; Wolkov Harvey B; Sause William T; Rubin Philip; Lawton Colleen A
Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
International journal of radiation oncology, biology, physics 2006;64(4):1162-7.
2006: Ray Michael E; Thames Howard D; Levy Larry B; Horwitz Eric M; Kupelian Patrick A; Martinez Alvaro A; Michalski Jeff M; Pisansky Thomas M; Shipley William U; Zelefsky Michael J; Zietman Anthony L; Kuban Deborah A
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.
International journal of radiation oncology, biology, physics 2006;64(4):1140-50.
2005: Kupelian Patrick; Thames Howard; Levy Larry; Horwitz Eric; Martinez Alvaro; Michalski Jeff; Pisansky Thomas; Sandler Howard; Shipley William; Zelefsky Michael; Zietman Anthony; Kuban Deborah
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
International journal of radiation oncology, biology, physics 2005;63(3):795-9.
2005: Zietman Anthony L; DeSilvio Michelle L; Slater Jerry D; Rossi Carl J; Miller Daniel W; Adams Judith A; Shipley William U
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(10):1233-9.
2005: Zhang Min; Mukherjee Neelanjan; Bermudez R Scott; Latham Douglas E; Delaney Meaghan A; Zietman Anthony L; Shipley William U; Chakravarti Arnab
Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
The Prostate 2005;64(3):293-302.
2005: Zietman Anthony L; Christodouleas John P; Shipley William U
PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failure.
International journal of radiation oncology, biology, physics 2005;62(3):714-8.
2005: Chakravarti Arnab; Winter Kathryn; Wu Chin-Lee; Kaufman Donald; Hammond Elizabeth; Parliament Matthew; Tester William; Hagan Michael; Grignon David; Heney Niall; Pollack Alan; Sandler Howard; Shipley William
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
International journal of radiation oncology, biology, physics 2005;62(2):309-17.
2005: Kuban Deborah A; Thames Howard D; Shipley William U
Defining recurrence after radiation for prostate cancer.
The Journal of urology 2005;173(6):1871-8.
2005: Horwitz Eric M; Thames Howard D; Kuban Deborah A; Levy Larry B; Kupelian Patrick A; Martinez Alvaro A; Michalski Jeffrey M; Pisansky Thomas M; Sandler Howard M; Shipley William U; Zelefsky Michael J; Hanks Gerald E; Zietman Anthony L
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.
The Journal of urology 2005;173(3):797-802.
2005: Kupelian Patrick; Kuban Deborah; Thames Howard; Levy Larry; Horwitz Eric; Martinez Alvaro; Michalski Jeff; Pisansky Thomas; Sandler Howard; Shipley William; Zelefsky Michael; Zietman Anthony
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
International journal of radiation oncology, biology, physics 2005;61(2):415-9.
2005: Kuban Deborah; Thames Howard; Levy Larry; Horwitz Eric; Kupelian Patrick; Martinez Alvaro; Michalski Jeff; Pisansky Thomas; Sandler Howard; Shipley William; Zelefsky Michael; Zietman Anthony
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
International journal of radiation oncology, biology, physics 2005;61(2):409-14.
2005: Montie James E; Bahnson Robert R; Cohen Samuel M; Drucker Beverly; Eisenberger Mario A; El-Galley Rizk; Herr Harry W; Hudes Gary R; Kuzel Timothy M; Lange Paul H; Patterson Anthony; Pollack Alan; Richie Jerome P; Seigne John; Shipley William U; Small Eric J; Trump Donald L; Walther Philip J; Wilson Timothy G;
Bladder cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(1):4-5, 19-34.
2005: Shipley William U; Zietman Anthony L; Kaufman Donald S; Coen John J; Sandler Howard M
Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences.
Seminars in radiation oncology 2005;15(1):36-41.
2004: Czito Brian; Zietman Anthony; Kaufman Donald; Skowronski Uri; Shipley William
Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
The Journal of urology 2004;172(4 Pt 1):1271-5.
2004: Li Rile; Heydon Kateri; Hammond M Elizabeth; Grignon David J; Roach Mack; Wolkov Harvey B; Sandler Howard M; Shipley William U; Pollack Alan
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4118-24.
2004: Pollack A; DeSilvio M; Khor L-Y; Li R; Al-Saleem T I; Hammond M E; Venkatesan V; Lawton C A; Roach M; Shipley W U; Hanks G E; Sandler H M
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2133-40.
2004: Michaelson M D; Shipley W U; Heney N M; Zietman A L; Kaufman D S
Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.
British journal of cancer 2004;90(3):578-81.
2004: Kaufman Donald S; Shipley William U; McDougal W Scott; Young Robert H
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2004. A 57-year-old man with invasive transitional-cell carcinoma of the bladder.
The New England journal of medicine 2004;350(4):394-402.
2004: Zietman A L; Chung C S; Coen J J; Shipley W U
10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study.
The Journal of urology 2004;171(1):210-4.
2003: Hanks Gerald E; Pajak Thomas F; Porter Arthur; Grignon David; Brereton Harmart; Venkatesan Varagur; Horwitz Eric M; Lawton Colleen; Rosenthal Seth A; Sandler Howard M; Shipley William U;
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3972-8.
2003: Thames Howard; Kuban Deborah; Levy Larry; Horwitz Eric M; Kupelian Patrick; Martinez Alvaro; Michalski Jeffrey; Pisansky Thomas; Sandler Howard; Shipley William; Zelefsky Michael; Zietman Anthony
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.
International journal of radiation oncology, biology, physics 2003;57(4):929-43.
2003: Kuban Deborah A; Thames Howard D; Levy Larry B; Horwitz Eric M; Kupelian Patrick A; Martinez Alvaro A; Michalski Jeff M; Pisansky Thomas M; Sandler Howard M; Shipley William U; Zelefsky Michael J; Zietman Anthony L
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.
International journal of radiation oncology, biology, physics 2003;57(4):915-28.
2003: Zietman Anthony L; Sacco Dianne; Skowronski Uri; Gomery Pablo; Kaufman Donald S; Clark Jack A; Talcott James A; Shipley William U
Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors.
The Journal of urology 2003;170(5):1772-6.
2003: Hagan Michael P; Winter Kathryn A; Kaufman Donald S; Wajsman Zev; Zietman Anthony L; Heney Naill M; Toonkel Leonard M; Jones Christopher U; Roberts John D; Shipley William U
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
International journal of radiation oncology, biology, physics 2003;57(3):665-72.
2003: Coen John J; Chung Christine S; Shipley William U; Zietman Anthony L
Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis.
International journal of radiation oncology, biology, physics 2003;57(3):621-8.
2003: Chakravarti A; Heydon K; Wu C L; Hammond E; Pollack A; Roach M; Wolkov H; Okunieff P; Cox J; Fontanesi J; Abrams R; Pilepich M; Shipley W;
Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3328-34.
2003: Shipley William U; Kaufman Donald S; Tester William J; Pilepich Miljenko V; Sandler Howard M;
Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
Cancer 2003;97(8 Suppl):2115-9.
2003: Pollack A; Grignon D J; Heydon K H; Hammond E H; Lawton C A; Mesic J B; Fu K K; Porter A T; Abrams R A; Shipley W U
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1238-48.
2003: Coen John J; Zietman Anthony L; Shipley William U
Prostatectomy or watchful waiting in prostate cancer.
The New England journal of medicine 2003;348(2):170-1; author reply 170-1.
2002: Shipley William U; Lu J D; Pilepich Michael V; Heydon Kateri; Roach Mack; Wolkov Harvey B; Sause William T; Rubin Philip; Lawton Colleen A; Machtay Mitchell
Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10.
International journal of radiation oncology, biology, physics 2002;54(5):1302-10.
2002: Yock Torunn I; Zietman Anthony L; Shipley William U; Thakral Harjot K; Coen John J
Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2002;54(2):420-6.
2002: Coen John J; Zietman Anthony L; Thakral Harjot; Shipley William U
Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3199-205.
2002: Zietman Anthony; Thakral Harjot; Skowronski Uri; Shipley William
Freedom from castration: an alternative end point for men with localized prostate cancer treated by external beam radiation therapy.
International journal of radiation oncology, biology, physics 2002;53(5):1152-9.
2002: Shipley W U; Kaufman D S; Zehr E; Heney N M; Lane S C; Thakral H K; Althausen A F; Zietman A L
Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.
Urology 2002;60(1):62-7; discussion 67-8.
2002: Chawla Ashish K; Thakral Harjot K; Zietman Anthony L; Shipley William U
Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors.
Urology 2002;59(5):726-31.
2002: Gardner B G; Zietman A L; Shipley W U; Skowronski U E; McManus P
Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer.
The Journal of urology 2002;167(1):123-6.
2001: Zietman A L; Grocela J; Zehr E; Kaufman D S; Young R H; Althausen A F; Heney N M; Shipley W U
Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
Urology 2001;58(3):380-5.
2001: Sandler H; Shipley W U; Gomella L; Pienta K; Bard R H; Bruner D; Clark R; DeSilvio M; Gaspar L; Gillin M; Grignon D; Hammond E; Hanks G; Heydon K H; Kaufman D S; Lee W R; Michalski J; Mydlo J; Pisansky T; Pollack A; Porterfield H; Rifkin M; Roach M; Sanda M; True L; Vijayakumar S; Winter K A; Zeitman A;
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):28-38.
2000: Roach M 3RD; Lu J; Pilepich M V; Asbell S O; Mohiuddin M; Terry R; Grignon D; Lawton C; Shipley W; Cox J;
Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.
International journal of radiation oncology, biology, physics 2000;47(3):617-27.
2000: Chakravatri A; Zehr E M; Zietman A L; Shipley W U; Goggins W B; Finkelstein D M; Young R H; Chang E L; Wu C L
Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study.
Urology 2000;55(5):635-8.
2000: Zietman A L; Shipley W U; Kaufman D S
Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy.
Annals of medicine 2000;32(1):34-42.
2000: Kaufman D S; Winter K A; Shipley W U; Heney N M; Chetner M P; Souhami L; Zlotecki R A; Sause W T; True L D
The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.
The oncologist 2000;5(6):471-6.
1999: Shipley W U; Kaufman D S; Heney N M; Althausen A F; Zietman A L
An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.
The Journal of urology 1999;162(2):445-50; discussion 450-1.
1999: Shipley W U; Thames H D; Sandler H M; Hanks G E; Zietman A L; Perez C A; Kuban D A; Hancock S L; Smith C D
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
JAMA : the journal of the American Medical Association 1999;281(17):1598-604.
1999: Zietman A L; Zehr E M; Shipley W U
The long-term effect on PSA values of incidental prostatic irradiation in patients with pelvic malignancies other than prostate cancer.
International journal of radiation oncology, biology, physics 1999;43(4):715-8.
1998: Shipley W U; Winter K A; Kaufman D S; Lee W R; Heney N M; Tester W R; Donnelly B J; Venner P M; Perez C A; Murray K J; Doggett R S; True L D
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(11):3576-83.
1998: Zietman A L; Shipley W U; Kaufman D S; Zehr E M; Heney N M; Althausen A F; McGovern F J
A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
The Journal of urology 1998;160(5):1673-7.
1998: Shipley W U; Kaufman D S; Heney N M; Althausen A F; Zietman A L
An update of selective bladder preservation by combined modality therapy for invasive bladder cancer.
European urology 1998;33 Suppl 4():32-4.
1997: Zietman A L; Westgeest J C; Shipley W U
Radiation-based approaches to the management of T3 prostate cancer.
Seminars in urologic oncology 1997;15(4):230-8.
1997: Shipley W U; Zietman A L; Kaufman D S; Althausen A F; Heney N M
Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation.
International journal of radiation oncology, biology, physics 1997;39(4):937-43.
1997: Kanady K E; Shipley W U; Zietman A L; Kaufman D S; Althausen A F; Heney N M
Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer.
Seminars in surgical oncology 1997;13(5):359-64.
1997: Zietman A L; Shipley W U; Heney N M; Althausen A F
The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer.
Seminars in urologic oncology 1997;15(3):161-8.
1997: Morris M M; Dallow K C; Zietman A L; Park J; Althausen A; Heney N M; Shipley W U
Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer.
International journal of radiation oncology, biology, physics 1997;38(4):731-6.
1997: Su C K; Shipley W U
Bowenoid papulosis: a benign lesion of the shaft of the penis misdiagnosed as squamous carcinoma.
The Journal of urology 1997;157(4):1361-2.
1997: Zietman A L; Prince E A; Nakfoor B M; Shipley W U
Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results.
Urology 1997;49(3A Suppl):74-83.
1997: Kaufman D S; Shipley W U
Organ-sparing treatment of bladder cancer: an innovative approach.
American family physician 1997;55(4):1257-62.
1997: Kachnic L A; Kaufman D S; Heney N M; Althausen A F; Griffin P P; Zietman A L; Shipley W U
Bladder preservation by combined modality therapy for invasive bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1022-9.
1997: Pilepich M V; Caplan R; Byhardt R W; Lawton C A; Gallagher M J; Mesic J B; Hanks G E; Coughlin C T; Porter A; Shipley W U; Grignon D
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1013-21.
1997: Grignon D J; Caplan R; Sarkar F H; Lawton C A; Hammond E H; Pilepich M V; Forman J D; Mesic J; Fu K K; Abrams R A; Pajak T F; Shipley W U; Cox J D
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
Journal of the National Cancer Institute 1997;89(2):158-65.
1996: Colvett K T; Althausen A F; Bassil B; Heney N M; McGovern F V; Young H H; Kaufman D S; Zietman A L; Shipley W U
Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Journal of surgical oncology 1996;63(3):201-8.
1996: Hartford A C; Niemierko A; Adams J A; Urie M M; Shipley W U
Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.
International journal of radiation oncology, biology, physics 1996;36(3):721-30.
1996: Douglas R M; Kaufman D S; Zietman A L; Althausen A F; Heney N M; Shipley W U
Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer.
Seminars in oncology 1996;23(5):614-20.
1996: Zietman A L; Tibbs M K; Dallow K C; Smith C T; Althausen A F; Zlotecki R A; Shipley W U
Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):159-62.
1996: Liu M C; Zietman A L; Shipley W U
Organ preservation approaches with radiation therapy in muscle-invasive bladder carcinoma.
Annals of the Academy of Medicine, Singapore 1996;25(3):441-7.
1996: Fagundes M A; Zietman A L; Althausen A F; Coen J J; Shipley W U
The management of spermatic cord sarcoma.
Cancer 1996;77(9):1873-6.
1996: Kachnic L A; Shipley W U; Griffin P P; Zietman A L; Kaufman D S; Althausen A F; Heney N M
Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.
The cancer journal from Scientific American 1996;2(2):79-84.
1996: Zietman A L; Dallow K C; McManus P A; Heney N M; Shipley W U
Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease.
Urology 1996;47(2):236-9.
1995: Zietman A L; Shipley W U; Kaufman D S; Esrig D; Lytton B
Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
Contemporary urology 1995;7(7):23-4, 29, 32, passim.
1995: Zietman A L; Coen J J; Dallow K C; Shipley W U
The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome.
International journal of radiation oncology, biology, physics 1995;32(2):287-92.
1995: Shipley W U; Verhey L J; Munzenrider J E; Suit H D; Urie M M; McManus P L; Young R H; Shipley J W; Zietman A L; Biggs P J
Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
International journal of radiation oncology, biology, physics 1995;32(1):3-12.
1994: Shipley W U; Zietman A L; Hanks G E; Coen J J; Caplan R J; Won M; Zagars G K; Asbell S O
Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor.
The Journal of urology 1994;152(5 Pt 2):1799-805.
1994: Zietman A L; Shipley W U; Coen J J
Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.
The Journal of urology 1994;152(5 Pt 2):1806-12.
1994: Centeno B A; Zietman A L; Shipley W U; Sobczak M L; Shipley J W; Preffer F I; Boyle B J; Colvin R B
Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
International journal of radiation oncology, biology, physics 1994;30(2):309-15.
1994: Willett C G; Zietman A L; Shipley W U; Coen J J
The effect of pelvic radiation therapy on serum levels of prostate specific antigen.
The Journal of urology 1994;151(6):1579-81.
1994: Zietman A L; Coen J J; Shipley W U; Willett C G; Efird J T
Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.
The Journal of urology 1994;151(3):640-5.
1994: Nakfoor B M; Shipley W U; Zietman A L
Early stage testicular seminoma: the role of radiation therapy following orchiectomy.
Frontiers of radiation therapy and oncology 1994;28():183-95.
1993: Kaufman D S; Shipley W U; Griffin P P; Heney N M; Althausen A F; Efird J T
Selective bladder preservation by combination treatment of invasive bladder cancer.
The New England journal of medicine 1993;329(19):1377-82.
1993: Zietman A L; Shipley W U; Kaufman D S
The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder.
International journal of radiation oncology, biology, physics 1993;27(1):161-70.
1993: Zietman A L; Coen J J; Shipley W U; Althausen A F
Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure.
Urology 1993;42(3):292-8; discussion 298-9.
1993: Benk V A; Adams J A; Shipley W U; Urie M M; McManus P L; Efird J T; Willett C G; Goitein M
Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma.
International journal of radiation oncology, biology, physics 1993;26(3):551-7.
1993: Zietman A L; Shipley W U; Willett C G
Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications.
Cancer 1993;71(3 Suppl):959-69.
1993: Shipley W U; Kaufmann D S; Griffin P P; Althausen A F; Heney N M; Prout G R
Radiochemotherapy for invasive carcinoma of the bladder.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;126():207-16.
1992: Anscher M S; Marks L B; Shipley W U
The role of radiotherapy in patients with advanced seminomatous germ cell tumors. Controversies in management. Part 2.
Oncology (Williston Park, N.Y.) 1992;6(8):97-104; discussion 107-8, 110.
1992: Hug E B; Donnelly S M; Shipley W U; Heney N M; Kaufman D S; Preffer F I; Schwartz S M; Colvin R B; Althausen A F
Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy.
The Journal of urology 1992;148(1):47-51.
1992: Marks L B; Anscher M S; Shipley W U
Radiation therapy for testicular seminoma: controversies in the management of early-stage disease.
Oncology (Williston Park, N.Y.) 1992;6(6):43-8; discussion 51-2.
1992: Shipley W U; Kaufman D S; Griffin P; Althausen A F; Heney N M; Prout G R
Radio-chemotherapy for invasive carcinoma of the bladder.
Frontiers of radiation therapy and oncology 1992;26():142-52.
1991: Marks L B; Anscher M S; Shipley W U
The role of radiation therapy in the treatment of testicular germ cell tumors.
Hematology/oncology clinics of North America 1991;5(6):1143-72.
1991: Dugan T C; Shipley W U; Young R H; Verhey L J; Althausen A F; Heney N M; McManus P L; Abraham E H
Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.
The Journal of urology 1991;146(5):1313-6.
1991: Lawton C A; Won M; Pilepich M V; Asbell S O; Shipley W U; Hanks G E; Cox J D; Perez C A; Sause W T; Doggett S R
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.
International journal of radiation oncology, biology, physics 1991;21(4):935-9.
1991: Marks L B; Shipley W U; Walker T G; Waltman A C
Role of lymphangiography in staging testicular seminoma.
Urology 1991;38(3):264-6.
1991: Fung C Y; Shipley W U; Young R H; Griffin P P; Convery K M; Kaufman D S; Althausen A F; Heney N M; Prout G R
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1533-42.
1991: Prout G R; Shipley W U; Kaufman D S; Griffin P P; Heney N M
Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive bladder cancer. A bladder-sparing trial.
The Urologic clinics of North America 1991;18(3):547-54.
1991: Flynn D F; Shipley W U
Management of spinal cord compression secondary to metastatic prostatic carcinoma.
The Urologic clinics of North America 1991;18(1):145-52.
1990: Prout G R; Shipley W U; Kaufman D S; Heney N M; Griffin P P; Althausen A F; Bassil B; Nocks B N; Parkhurst E C; Young H H
Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
The Journal of urology 1990;144(5):1128-34; discussion 1134-6.
1990: Prout G R; Shipley W U; Kaufman D S; Griffin P P; Heney N M
A progress report on the results of multimodality therapy for muscle-invasive bladder cancer.
Seminars in urology 1990;8(3):201-4.
1990: Marks L B; Rutgers J L; Shipley W U; Walker T G; Stracher M S; Waltman A C; Geller S C
Testicular seminoma: clinical and pathological features that may predict para-aortic lymph node metastases.
The Journal of urology 1990;143(3):524-7.
1990: Shipley W U; Prout G R; Kaufman D S
Bladder cancer. Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumors.
Cancer 1990;65(3 Suppl):675-83.
1990: Shipley W U; Kaufman D S; Heney N M; Griffin P P; Althausen A F; Prout G R
The integration of chemotherapy, radiotherapy and transurethral surgery in bladder-sparing approaches for patients with invasive tumors.
Progress in clinical and biological research 1990;353():85-94.
1990: Cardenosa G; Papanicolaou N; Fung C Y; Tung G A; Yoder I C; Althausen A F; Shipley W U
Spermatic cord sarcomas: sonographic and CT features.
Urologic radiology 1990;12(3):163-7.
1988: Marks L B; Kaufman S D; Prout G R; Heney N M; Griffin P P; Shipley W U
Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemotherapy and pelvic irradiation plus cisplatin.
International journal of radiation oncology, biology, physics 1988;15(4):877-83.
1988: Shipley W U; Kaufman S D; Prout G R
The role of radiation therapy and chemotherapy in the treatment of invasive carcinoma of the urinary bladder.
Seminars in oncology 1988;15(4):390-5.
1988: Sailer S L; Shipley W U; Wang C C
Carcinoma of the female urethra: a review of results with radiation therapy.
The Journal of urology 1988;140(1):1-5.
1988: Shipley W
Intraoperative electron-beam therapy and other bladder-sparing approaches to bladder carcinoma.
Urology 1988;31(2 Suppl):18-21.
1988: Shipley W U; Prout G R; Coachman N M; McManus P L; Healey E A; Althausen A F; Heney N M; Parkhurst E C; Young H H; Shipley J W
Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981).
NCI monographs : a publication of the National Cancer Institute 1988;(7):67-73.
1988: Shipley W U
Review of factors predicting improved tumor control and survival from invasive bladder carcinoma following external beam radiation therapy.
Progress in clinical and biological research 1988;260():437-46.
1987: Shipley W U; Kaufman S D; Prout G R
Intraoperative radiation therapy in patients with bladder cancer. A review of techniques allowing improved tumor doses and providing high cure rates without loss of bladder function.
Cancer 1987;60(7):1485-8.
1987: Shipley W U; Prout G R; Kaufman S D; Perrone T L
Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation.
Cancer 1987;60(3 Suppl):514-20.
1987: Tepper J E; Shipley W U; Warshaw A L; Nardi G L; Wood W C; Orlow E L
The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):579-84.
1987: Shipley W U; Bagshaw M A; Prout G R
The success of radiation therapy in controlling prostatic cancer within the treated field.
Progress in clinical and biological research 1987;243B():199-212.
1986: Willett C G; Tepper J E; Orlow E L; Shipley W U
Renal complications secondary to radiation treatment of upper abdominal malignancies.
International journal of radiation oncology, biology, physics 1986;12(9):1601-4.
1985: Mirimanoff R O; Shipley W U; Dosoretz D E; Meyer J E
Pure seminoma of the testis: the results of radiation therapy in patients with elevated human chorionic gonadotropin titers.
The Journal of urology 1985;134(6):1124-6.
1984: Tepper J E; Gunderson L L; Orlow E; Cohen A M; Hedberg S E; Shipley W U; Blitzer P H; Rich T
Complications of intraoperative radiation therapy.
International journal of radiation oncology, biology, physics 1984;10(10):1831-9.
1984: Shipley W U; Wood W C; Tepper J E; Warshaw A L; Orlow E L; Kaufman S D; Battit G E; Nardi G L
Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.
Annals of surgery 1984;200(3):289-96.
1983: Heney N M; Proppe K; Prout G R; Griffin P P; Shipley W U
Invasive bladder cancer: tumor configuration, lymphatic invasion and survival.
The Journal of urology 1983;130(5):895-7.
1983: Gunderson L L; Cohen A C; Dosoretz D D; Shipley W U; Hedberg S E; Wood W C; Rodkey G V; Suit H D
Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost +/- resection.
International journal of radiation oncology, biology, physics 1983;9(11):1597-606.
1983: Dosoretz D E; Gunderson L L; Hedberg S; Hoskins B; Blitzer P H; Shipley W; Cohen A
Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas.
Cancer 1983;52(5):814-8.
1983: Gunderson L L; Dosoretz D E; Hedberg S E; Blitzer P H; Rodkey G; Hoskins B; Shipley W U; Cohen A C
Low-dose preoperative irradiation, surgery, and elective postoperative radiation therapy for resectable rectum and rectosigmoid carcinoma.
Cancer 1983;52(3):446-51.
1983: Duttenhaver J R; Shipley W U; Perrone T; Verhey L J; Goitein M; Munzenrider J E; Prout G R; Parkhurst E C; Suit H D
Protons or megavoltage X-rays as boost therapy for patients irradiated for localized prostatic carcinoma. An early phase I/II comparison.
Cancer 1983;51(9):1599-604.
1982: Suit H; Goitein M; Munzenrider J; Verhey L; Blitzer P; Gragoudas E; Koehler A M; Urie M; Gentry R; Shipley W; Urano M; Duttenhaver J; Wagner M
Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy.
International journal of radiation oncology, biology, physics 1982;8(12):2199-205.
1981: Blitzer P H; Dosoretz D E; Proppe K H; Shipley W U
Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature.
The Journal of urology 1981;126(5):611-4.
1981: Dosoretz D E; Shipley W U; Blitzer P H; Gilbert S; Prat J; Parkhurst E; Wang C C
Megavoltage irradiation for pure testicular seminoma: results and patterns of failure.
Cancer 1981;48(10):2184-90.
1981: Prout G R; Griffin P P; Daly J J; Shipley W U
Nodal involvement as prognostic indicator in prostatic carcinoma.
Urology 1981;17(Suppl 3):72-9.
1980: Prout G R; Heaney J A; Griffin P P; Daly J J; Shipley W U
Nodal involvement as a prognostic indicator in patients with prostatic carcinoma.
The Journal of urology 1980;124(2):226-31.
1980: Suit H D; Goitein M; Munzenrider J E; Verhey L; Gragoudas E; Koehler A M; Urano M; Shipley W U; Linggood R M; Friedberg C; Wagner M
Clinical experience with proton beam radiation therapy.
Journal of the Canadian Association of Radiologists 1980;31(1):35-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

William Shipley

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of William Shipley (preview)

All Publications